Proceedings of the 12th International Conference on Thrombosis and Hemostasis Issues in Cancer, 2024
-
Welcome to the 12th ICTHIC!
Published: 16 May 20241199PDF: 121 -
Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape
Published: 29 February 20241161PDF: 154 -
Patient and public involvement in cancer-associated thrombosis research: necessary or glorified tokenism?
Published: 16 May 2024930PDF: 81 -
Endothelial cell dysfunction in cancer: a not-so-innocent bystander
Published: 16 May 2024766PDF: 70 -
Machine learning in cancer-associated thrombosis: hype or hope in untangling the clot
Published: 16 May 2024615PDF: 74 -
Cancer-associated ischemic stroke: current knowledge and future directions
Published: 16 May 2024365PDF: 110 -
Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review
Published: 16 May 2024341PDF: 94 -
Venous thromboembolism and mortality in patients with hematological malignancies
Published: 16 May 2024213PDF: 84 -
Cancer complicated by thrombosis and thrombocytopenia: still a therapeutic dilemma
Published: 16 May 2024212PDF: 67 -
Coagulome and tumor microenvironment: impact of oncogenes, cellular heterogeneity and extracellular vesicles
Published: 16 May 2024198PDF: 64 -
New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis
Published: 16 May 2024205PDF: 91 -
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis
Published: 16 May 2024264PDF: 113 -
Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis
Published: 16 May 2024275PDF: 125 -
Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy
Published: 16 May 2024168PDF: 88
